In vitro- forsøg tyder på, at der er usandsynligt, at vareniclin ændrer farmakokinetikken for stoffer, der primært metaboliseres af cytochrom P450- enzymer.
In vitro studies indicate that varenicline is unlikely to alter the pharmacokinetics of compounds that are primarily metabolised by cytochrome P450 enzymes.